These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8832603)

  • 1. Effects of hypercholesterolemia of renal hemodynamics: study in patients with nephrotic syndrome.
    Fuiano G; Esposito C; Sepe V; Colucci G; Bovino M; Rosa M; Balletta M; Bellinghieri G; Conte G; Cianciaruso B; Dal Canton A
    Nephron; 1996; 73(3):430-5. PubMed ID: 8832603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome.
    Toto RD; Grundy SM; Vega GL
    Am J Nephrol; 2000; 20(1):12-7. PubMed ID: 10644862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.
    Dupuis J; Tardif JC; Cernacek P; Théroux P
    Circulation; 1999 Jun; 99(25):3227-33. PubMed ID: 10385495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R; Robinson G; Tilyard M; Gurr E
    N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia.
    Lee IT; Lee WJ; Ou HC; Huang CN; Sheu WH
    Metabolism; 2009 Mar; 58(3):416-20. PubMed ID: 19217460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins improve visual field alterations related to hypercholesterolemia.
    Alcalá A; Jansen S; Téllez T; Gómez-Huelgas R; Pérez O; Egido J; Farkouh ME
    Atherosclerosis; 2010 Apr; 209(2):510-4. PubMed ID: 19892351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.
    Newby DE; Witherow FN; Wright RA; Bloomfield P; Ludlam CA; Boon NA; Fox KA; Webb DJ
    Heart; 2002 Jan; 87(1):48-53. PubMed ID: 11751664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of ciclosporin on renal hemodynamics and urinary protein excretion in patients with the nephrotic syndrome.
    Fuiano G; Conte G; Sepe V; Balletta M; Cianfrone P; Libetta C; Romano G; Sabbatini M; Bisesti V
    Nephron; 1991; 59(3):369-74. PubMed ID: 1758524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.
    Murrow JR; Sher S; Ali S; Uphoff I; Patel R; Porkert M; Le NA; Jones D; Quyyumi AA
    J Clin Lipidol; 2012; 6(1):42-9. PubMed ID: 22264573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of plasma cholesterol reduction by pravastatin on the functional properties of forearm arteries in hypercholesterolemic patients.
    Baldassarre D; Busnach G; Amato M; Pazzucconi F; Sirtori CR
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):108-17. PubMed ID: 10464783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal sodium retention during volume expansion in experimental nephrotic syndrome.
    Bernard DB; Alexander EA; Couser WG; Levinsky NG
    Kidney Int; 1978 Nov; 14(5):478-85. PubMed ID: 750693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of pravastatin on hypercholesterolemia associated with proteinuria].
    Aranda Arcas JL; Sánchez R; Guijarro C; Araque A; Pulido F; Praga M; Damiano A
    An Med Interna; 1994 Nov; 11(11):523-7. PubMed ID: 7654898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine.
    Andrade L; Campos SB; Seguro AC
    Kidney Int; 1998 Jun; 53(6):1736-42. PubMed ID: 9607206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.